German pharmaceutical giant Bayer on Thursday updated its full-year guidance following a stronger-than-expected performance ...

Full-year 2025 net sales outlook is set at $3.3 billion to $3.4 billion or down 1% to up 1% year-over-year, below initial guidance from February, due to lower assumptions for U.S. wholesale and DTC ...

New home construction in the U.S. ticked up in June after hitting a five-year low in May, but housing starts and completions remain low.

Once approved, the Dixie Meadows geothermal project would be built directly adjacent to the only known habitat of the endangered Dixie Valley toad – a 760-acres of wetland habitat fed by hot springs ...

After four nights of riots and clashes with migrants, Spain will step up its investigation into possible crimes committed by far-right.

Moody's on Thursday hiked its rating for the government of Argentina's long-term foreign currency and local currency issuer ratings to "Caa1" from "Caa3", up two notches though it remains in so ...

Chicago Bears rookie outlook: Will Kyle Monangai move up the running back depth chart and contribute?

Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong second-quarter sales of key drugs such as Kisqali, and said potential new U.S. tariffs would not ...

Donald Trump’s trade war has homebuilders down in the dumps, but they’ve become slightly more optimistic of late.

Can Bears seventh-round pick Kyle Monangai earn playing time as a rookie? Here’s what the former Rutgers running back needs to prove during training camp.

Twenty-one running backs were selected in the 2025 NFL draft ahead of Kyle Monangai. Chicago Bears general manager Ryan Poles selected Monangai in the seventh round (233rd overall) with the team ...

Novartis launched a share buyback of up to $10 billion and raised its full-year profit guidance after continued demand for key drugs fueled growth in second-quarter sales and earnings.